Emerging roles of small extracellular vesicles in metabolic reprogramming and drug resistance in cancers

Abstract

Studies of carcinogenic metabolism have shown that cancer cells have significant metabolic adaptability and that their metabolic dynamics undergo extensive reprogramming, which is a fundamental feature of cancer. The Warburg effect describes the preference of cancer cells for glycolysis over oxidative phosphorylation (OXPHOS), even under aerobic conditions. However, metabolic reprogramming in cancer cells involves not only glycolysis but also changes in lipid and amino acid metabolism. The mechanisms of these metabolic shifts are critical for the discovery of novel cancer therapeutic targets. Despite advances in the field of oncology, chemotherapy resistance, including multidrug resistance, remains a challenge. Research has revealed a correlation between metabolic reprogramming and anticancer drug resistance, but the underlying complex mechanisms are not fully understood. In addition, small extracellular vesicles (sEVs) may play a role in expanding metabolic reprogramming and promoting the development of drug resistance by mediating intercellular communication. The aim of this review is to assess the metabolic reprogramming processes that intersect with resistance to anticancer therapy, with particular attention given to the changes in glycolysis, lipid metabolism, and amino acid metabolism that accompany this phenomenon. In addition, the role of sEVs in disseminating metabolic reprogramming and promoting the development of drug-resistant phenotypes will be critically evaluated.

Keywords

Small extracellular vesicles / metabolic reprogramming / drug resistance / neoplasms / glycolysis / lipid metabolism / amino acid metabolism

References

[1] Kalluri R.The biology, function, and biomedical applications of exosomes.Science2020;367:eaau6977 PMCID:PMC7717626

[2] Platko K,Aziz T.The role of circulating extracellular vesicles in breast cancer classification and molecular subtyping.Breast J2019;25:691-5

[3] Vietri M,Stenmark H.The many functions of ESCRTs.Nat Rev Mol Cell Biol2020;21:25-42

[4] Song L,Han X.KIBRA controls exosome secretion via inhibiting the proteasomal degradation of Rab27a.Nat Commun2019;10:1639 PMCID:PMC6456494

[5] Hong W.Tethering the assembly of SNARE complexes.Trends Cell Biol2014;24:35-43

[6] Wu H,Liu J.The role and application of small extracellular vesicles in gastric cancer.Mol Cancer2021;20:71 PMCID:PMC8081769

[7] Li K,Li A,Liu X.Exosomes play roles in sequential processes of tumor metastasis.Int J Cancer2019;144:1486-95

[8] Hernández-Barranco A,Peinado H.Could extracellular vesicles contribute to generation or awakening of “sleepy” metastatic niches?.Front Cell Dev Biol2021;9:625221 PMCID:PMC7960773

[9] Li I.Exosomes in the tumor microenvironment as mediators of cancer therapy resistance.Mol Cancer2019;18:32 PMCID:PMC6397467

[10] Dai Y,Li J,Yang H.Shikonin inhibited glycolysis and sensitized cisplatin treatment in non-small cell lung cancer cells via the exosomal pyruvate kinase M2 pathway.Bioengineered2022;13:13906-18 PMCID:PMC9275963

[11] Faict S,D'Auria L.The transfer of sphingomyelinase contributes to drug resistance in multiple myeloma.Cancers2019;11:1823 PMCID:PMC6966559

[12] Hanahan D.Hallmarks of cancer: new dimensions.Cancer Discov2022;12:31-46

[13] Warburg O.On the origin of cancer cells.Science1956;123:309-14

[14] Zaal EA.The influence of metabolism on drug response in cancer.Front Oncol2018;8:500 PMCID:PMC6230982

[15] Sun H,Zheng X,Wei X.Correlation between serum lipid levels and endocrine resistance in patients with ER-positive breast cancer.Medicine2023;102:e35048 PMCID:PMC10578763

[16] Yang SM,Lee JY,Lee JM.Regulation of glucose and glutamine metabolism to overcome cisplatin resistance in intrahepatic cholangiocarcinoma.BMB Rep2023;56:600-5 PMCID:PMC10689087

[17] Nussinov R,Jang H.Anticancer drug resistance: an update and perspective.Drug Resist Updat2021;59:100796 PMCID:PMC8810687

[18] Assaraf YG,Gonçalves AC.The multi-factorial nature of clinical multidrug resistance in cancer.Drug Resist Updat2019;46:100645

[19] Theile D.Acquired ABC-transporter overexpression in cancer cells: transcriptional induction or Darwinian selection?.Naunyn Schmiedebergs Arch Pharmacol2021;394:1621-32 PMCID:PMC8298356

[20] Wang JQ,Cai CY.Multidrug resistance proteins (MRPs): structure, function and the overcoming of cancer multidrug resistance.Drug Resist Updat2021;54:100743

[21] Ozyerli-Goknar E.Epigenetic deregulation of apoptosis in cancers.Cancers2021;13:3210 PMCID:PMC8267644

[22] Li LY,Chen XS,Cheng Y.DNA repair pathways in cancer therapy and resistance.Front Pharmacol2020;11:629266 PMCID:PMC7898236

[23] Desbats MA,Prayer-Galetti T.Metabolic plasticity in chemotherapy resistance.Front Oncol2020;10:281 PMCID:PMC7068907

[24] Lin J,Liang J.The roles of glucose metabolic reprogramming in chemo- and radio-resistance.J Exp Clin Cancer Res2019;38:218 PMCID:PMC6533757

[25] Hamadneh L,Alhusban A.Upregulation of PI3K/AKT/PTEN pathway is correlated with glucose and glutamine metabolic dysfunction during tamoxifen resistance development in MCF-7 cells.Sci Rep2020;10:21933 PMCID:PMC7736849

[26] Sun H,Wang X.Aurora-A/SOX8/FOXK1 signaling axis promotes chemoresistance via suppression of cell senescence and induction of glucose metabolism in ovarian cancer organoids and cells.Theranostics2020;10:6928-45 PMCID:PMC7295065

[27] Chen T,Luo J.NSUN2 is a glucose sensor suppressing cGAS/STING to maintain tumorigenesis and immunotherapy resistance.Cell Metab2023;35:1782-98.e8 PMCID:PMC10726430

[28] Fang Y,Xie Y.Integration of glucose and cardiolipin anabolism confers radiation resistance of HCC.Hepatology2022;75:1386-401 PMCID:PMC9299851

[29] Park GB,Choi S,Kim D.Glucose deprivation enhances resistance to paclitaxel via ELAVL2/4-mediated modification of glycolysis in ovarian cancer cells.Anticancer Drugs2022;33:e370-80

[30] Hoshi S,Imai H.Upregulation of glucocorticoid receptor-mediated glucose transporter 4 in enzalutamide-resistant prostate cancer.Cancer Sci2021;112:1899-910 PMCID:PMC8088914

[31] Liu H,Jiang G.ALKBH5-mediated m6A demethylation of GLUT4 mRNA promotes glycolysis and resistance to HER2-targeted therapy in breast cancer.Cancer Res2022;82:3974-86

[32] Das CK,Parida PK,Mandal M.Lactate dehydrogenase A regulates autophagy and tamoxifen resistance in breast cancer.Biochim Biophys Acta Mol Cell Res2019;1866:1004-18

[33] Wang S,Ji N.Targeting ACYP1-mediated glycolysis reverses lenvatinib resistance and restricts hepatocellular carcinoma progression.Drug Resist Updat2023;69:100976

[34] Jiang X,Wang S.EIF4A3-induced circARHGAP29 promotes aerobic glycolysis in docetaxel-resistant prostate cancer through IGF2BP2/c-Myc/LDHA signaling.Cancer Res2022;82:831-45

[35] Chen X,Zhang Y.Long noncoding RNA DIO3OS induces glycolytic-dominant metabolic reprogramming to promote aromatase inhibitor resistance in breast cancer.Nat Commun2022;13:7160 PMCID:PMC9684133

[36] Zheng Y,Zhang Y.Hexokinase 2 confers radio-resistance in hepatocellular carcinoma by promoting autophagy-dependent degradation of AIMP2.Cell Death Dis2023;14:488 PMCID:PMC10390495

[37] Lee HJ,Ruan D.Non-proteolytic ubiquitination of Hexokinase 2 by HectH9 controls tumor metabolism and cancer stem cell expansion.Nat Commun2019;10:2625 PMCID:PMC6573064

[38] Ishfaq M,Riaz SK.Expression of HK2, PKM2, and PFKM is associated with metastasis and late disease onset in breast cancer patients.Genes2022;13:549 PMCID:PMC8955648

[39] Lypova N,Chesney J.Increased 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 activity in response to EGFR signaling contributes to non-small cell lung cancer cell survival.J Biol Chem2019;294:10530-43 PMCID:PMC6615683

[40] Jones BC,Clarke R.Treatment against glucose-dependent cancers through metabolic PFKFB3 targeting of glycolytic flux.Cancer Metastasis Rev2022;41:447-58

[41] Chang YC,Chiou J.Nonenzymatic function of Aldolase A downregulates miR-145 to promote the Oct4/DUSP4/TRAF4 axis and the acquisition of lung cancer stemness.Cell Death Dis2020;11:195 PMCID:PMC7080828

[42] Li Q,Bi Z.Rac1 activates non-oxidative pentose phosphate pathway to induce chemoresistance of breast cancer.Nat Commun2020;11:1456 PMCID:PMC7081201

[43] Qin Y,Guo C,Ma H.MeCP2 confers 5-fluorouracil resistance in gastric cancer via upregulating the NOX4/PKM2 pathway.Cancer Cell Int2022;22:86 PMCID:PMC8857846

[44] Zhou JW,Sun W.PGK1 facilities cisplatin chemoresistance by triggering HSP90/ERK pathway mediated DNA repair and methylation in endometrial endometrioid adenocarcinoma.Mol Med2019;25:11 PMCID:PMC6441178

[45] İlhan M.Non-metabolic functions of pyruvate kinase M2: PKM2 in tumorigenesis and therapy resistance.Neoplasma2022;69:747-54

[46] Wang X,Yang H.Exosome-delivered circRNA promotes glycolysis to induce chemoresistance through the miR-122-PKM2 axis in colorectal cancer.Mol Oncol2020;14:539-55 PMCID:PMC7053238

[47] Wong TL,Tan KV.CRAF methylation by PRMT6 regulates aerobic glycolysis-driven hepatocarcinogenesis via ERK-dependent PKM2 nuclear relocalization and activation.Hepatology2020;71:1279-96

[48] Cai Y,Meng JH.Puerarin suppresses glycolysis and increases cisplatin chemosensitivity in oral squamous cell carcinoma via FBXW7/mTOR signaling.Nutr Cancer2023;75:1028-37

[49] Zhang Y,Ren S.GPER-mediated stabilization of HIF-1α contributes to upregulated aerobic glycolysis in tamoxifen-resistant cells.Oncogene2023;42:184-97

[50] Ma L,Xu A.Activator of thyroid and retinoid receptor increases sorafenib resistance in hepatocellular carcinoma by facilitating the Warburg effect.Cancer Sci2020;111:2028-40 PMCID:PMC7293092

[51] Ma L.Metabolic symbiosis in chemoresistance: refocusing the role of aerobic glycolysis.Front Oncol2020;10:5 PMCID:PMC6992567

[52] Zong S,Fang W,Wang K.SIK2 promotes cisplatin resistance induced by aerobic glycolysis in breast cancer cells through PI3K/AKT/mTOR signaling pathway.Biosci Rep2020;BSR20201302

[53] Yu X,Mao X.Knockdown of FOXO6 inhibits glycolysis and reduces cell resistance to paclitaxel in HCC cells via PI3K/Akt signaling pathway.Onco Targets Ther2020;13:1545-56 PMCID:PMC7037170

[54] Feng J,Mao Y.Simvastatin re-sensitizes hepatocellular carcinoma cells to sorafenib by inhibiting HIF-1α/PPAR-γ/PKM2-mediated glycolysis.J Exp Clin Cancer Res2020;39:24 PMCID:PMC6993409

[55] He Y,Lu W.PGK1 contributes to tumorigenesis and sorafenib resistance of renal clear cell carcinoma via activating CXCR4/ERK signaling pathway and accelerating glycolysis.Cell Death Dis2022;13:118 PMCID:PMC8816910

[56] Xu F,Chen Q.LncRNA HIF1A-AS1 promotes gemcitabine resistance of pancreatic cancer by enhancing glycolysis through modulating the AKT/YB1/HIF1α pathway.Cancer Res2021;81:5678-91

[57] Qi CL,Zou Y.The IRF2/CENP-N/AKT signaling axis promotes proliferation, cell cycling and apoptosis resistance in nasopharyngeal carcinoma cells by increasing aerobic glycolysis.J Exp Clin Cancer Res2021;40:390 PMCID:PMC8662847

[58] Blagden SP,Mileshkin L.Phase IB dose escalation and expansion study of AKT inhibitor afuresertib with carboplatin and paclitaxel in recurrent platinum-resistant ovarian cancer.Clin Cancer Res2019;25:1472-8

[59] Nam SO,Miyata K.Warburg effect regulated by amphiregulin in the development of colorectal cancer.Cancer Med2015;4:575-87 PMCID:PMC4402072

[60] Wang G,Yin PH.New strategies for targeting glucose metabolism-mediated acidosis for colorectal cancer therapy.J Cell Physiol2018;234:348-68

[61] Choi MC,Choi YJ.Role of monocarboxylate transporter I/lactate dehydrogenase B-mediated lactate recycling in tamoxifen-resistant breast cancer cells.Arch Pharm Res2023;46:907-23

[62] Feng Y,Zhang S.PGAM1 promotes glycolytic metabolism and paclitaxel resistance via pyruvic acid production in ovarian cancer cells.Front Biosci2022;27:262

[63] Tan Y,Zhao G.Metabolic reprogramming from glycolysis to fatty acid uptake and beta-oxidation in platinum-resistant cancer cells.Nat Commun2022;13:4554 PMCID:PMC9356138

[64] Talebi A,Spotbeen X.Pharmacological induction of membrane lipid poly-unsaturation sensitizes melanoma to ROS inducers and overcomes acquired resistance to targeted therapy.J Exp Clin Cancer Res2023;42:92 PMCID:PMC10114329

[65] Menendez JA,Vander Steen T.Fatty acid synthase confers tamoxifen resistance to ER+/HER2+ breast cancer.Cancers2021;13:1132 PMCID:PMC7961649

[66] Gruslova A,Balinda HU.FASN inhibition as a potential treatment for endocrine-resistant breast cancer.Breast Cancer Res Treat2021;187:375-86

[67] Yu L,Du Y,Ling Y.FASN knockdown inhibited anoikis resistance of gastric cancer cells via P-ERK1/2/Bcl-xL pathway.Gastroenterol Res Pract2021;2021:6674204 PMCID:PMC8390150

[68] Yang T,Zhu X.High-dose radiation-resistant lung cancer cells stored many functional lipid drops through JAK2/p-STAT3/FASN pathway.J Cancer Res Clin Oncol2023;149:14169-83

[69] Souchek JJ,Houser L,Vu Q.Fatty acid synthase inhibitors enhance microtubule-stabilizing and microtubule-destabilizing drugs in taxane-resistant prostate cancer cells.ACS Pharmacol Transl Sci2023;6:1859-69 PMCID:PMC10714433

[70] Stamatakos S,Vergani E.Deregulated FASN expression in BRAF inhibitor-resistant melanoma cells unveils new targets for drug combinations.Cancers2021;13:2284 PMCID:PMC8126202

[71] Polonio-Alcalá E,Ruiz-Martínez S.AZ12756122, a novel fatty acid synthase inhibitor, decreases resistance features in EGFR-TKI resistant EGFR-mutated NSCLC cell models.Biomed Pharmacother2022;156:113942

[72] Talebi A,Rambow F.Sustained SREBP-1-dependent lipogenesis as a key mediator of resistance to BRAF-targeted therapy.Nat Commun2018;9:2500 PMCID:PMC6021375

[73] Bacci M,Smiriglia A.Acetyl-CoA carboxylase 1 controls a lipid droplet-peroxisome axis and is a vulnerability of endocrine-resistant ER⁺ breast cancer.Sci Transl Med2024;16:eadf9874

[74] Wang X,Gu Y.Fatty acid receptor GPR120 promotes breast cancer chemoresistance by upregulating ABC transporters expression and fatty acid synthesis.EBioMedicine2019;40:251-62 PMCID:PMC6413582

[75] Wang D.Eicosanoids and cancer.Nat Rev Cancer2010;10:181-93 PMCID:PMC2898136

[76] Fu H,Qi L.cPLA2α activates PI3K/AKT and inhibits Smad2/3 during epithelial-mesenchymal transition of hepatocellular carcinoma cells.Cancer Lett2017;403:260-70

[77] Cen B,Du Y.Prostaglandin E₂ induces miR675-5p to promote colorectal tumor metastasis via modulation of p53 expression.Gastroenterology2020;158:971-84.e10 PMCID:PMC7062589

[78] Chen L,Luo Y.cPLA2α mediates TGF-β-induced epithelial-mesenchymal transition in breast cancer through PI3k/Akt signaling.Cell Death Dis2017;8:e2728 PMCID:PMC5477578

[79] Wang T,Xu D.PTGES/PGE₂ signaling links immunosuppression and lung metastasis in Gprc5a-knockout mouse model.Oncogene2020;39:3179-94 PMCID:PMC7142021

[80] Wculek SK.Neutrophils support lung colonization of metastasis-initiating breast cancer cells.Nature2015;528:413-7 PMCID:PMC4700594

[81] Nosaka T,Tanabe Y.Alveolar macrophages drive hepatocellular carcinoma lung metastasis by generating leukotriene B₄.J Immunol2018;200:1839-52

[82] Li P,Shi J.Lung mesenchymal cells elicit lipid storage in neutrophils that fuel breast cancer lung metastasis.Nat Immunol2020;21:1444-55 PMCID:PMC7584447

[83] Krzeszinski JY,Cheng WY.Lipid osteoclastokines regulate breast cancer bone metastasis.Endocrinology2017;158:477-89 PMCID:PMC5460780

[84] Chen Q,Zhao M.High cholesterol in lipid rafts reduces the sensitivity to EGFR-TKI therapy in non-small cell lung cancer.J Cell Physiol2018;233:6722-32

[85] Zhang J,Wu Y.Cholesterol content in cell membrane maintains surface levels of ErbB2 and confers a therapeutic vulnerability in ErbB2-positive breast cancer.Cell Commun Signal2019;17:15 PMCID:PMC6383291

[86] Wu H,Chen Z,Zhang Z.MSC-induced lncRNA HCP5 drove fatty acid oxidation through miR-3619-5p/AMPK/PGC1α/CEBPB axis to promote stemness and chemo-resistance of gastric cancer.Cell Death Dis2020;11:233 PMCID:PMC7162922

[87] Jayawardhana AMDS,Datta P.Fatty acid-like Pt(IV) prodrugs overcome cisplatin resistance in ovarian cancer by harnessing CD36.Chem Commun2020;56:10706-9

[88] Mukherjee A,Daifotis HA.Adipocyte-induced FABP4 expression in ovarian cancer cells promotes metastasis and mediates carboplatin resistance.Cancer Res2020;80:1748-61 PMCID:PMC10656748

[89] Hillowe A,Wang L.Fatty acid binding protein 5 regulates docetaxel sensitivity in taxane-resistant prostate cancer cells.PLoS One2023;18:e0292483 PMCID:PMC10553314

[90] Watt MJ,Selth LA.Suppressing fatty acid uptake has therapeutic effects in preclinical models of prostate cancer.Sci Transl Med2019;11:eaau5758

[91] Alicea GM,Goldman AR.Changes in aged fibroblast lipid metabolism induce age-dependent melanoma cell resistance to targeted therapy via the fatty acid transporter FATP2.Cancer Discov2020;10:1282-95 PMCID:PMC7483379

[92] Du Q,Shi F.PGC1α/CEBPB/CPT1A axis promotes radiation resistance of nasopharyngeal carcinoma through activating fatty acid oxidation.Cancer Sci2019;110:2050-62 PMCID:PMC6550130

[93] Wan H,Zhu N.PGC-1α activator-induced fatty acid oxidation in tumor-infiltrating CTLs enhances effects of PD-1 blockade therapy in lung cancer.Tumori2020;106:55-63

[94] Liu Z,Wang W.CPT1A-mediated fatty acid oxidation confers cancer cell resistance to immune-mediated cytolytic killing.Proc Natl Acad Sci U S A2023;120:e2302878120 PMCID:PMC10523454

[95] Jiang C,Chen H.Targeting c-Jun inhibits fatty acid oxidation to overcome tamoxifen resistance in estrogen receptor-positive breast cancer.Cell Death Dis2023;14:653 PMCID:PMC10558541

[96] Heiserman JP,Nikpayam E.Targeting heat shock protein 27 and fatty acid oxidation augments cisplatin treatment in cisplatin-resistant ovarian cancer cell lines.Int J Mol Sci2023;24:12638 PMCID:PMC10454186

[97] Han S,Zhang X.CPT1A/2-mediated FAO enhancement - A metabolic target in radioresistant breast cancer.Front Oncol2019;9:1201 PMCID:PMC6873486

[98] Shen S,Souquere S.Melanoma persister cells are tolerant to BRAF/MEK inhibitors via ACOX1-mediated fatty acid oxidation.Cell Rep2020;33:108421

[99] Geneste A,Molina L.Adipocyte-conditioned medium induces resistance of breast cancer cells to lapatinib.BMC Pharmacol Toxicol2020;21:61 PMCID:PMC7427918

[100] Olzmann JA.Dynamics and functions of lipid droplets.Nat Rev Mol Cell Biol2019;20:137-55 PMCID:PMC6746329

[101] Grabner GF,Schweiger M.Lipolysis: cellular mechanisms for lipid mobilization from fat stores.Nat Metab2021;3:1445-65

[102] Nomura DK,Niessen S,Ng SW.Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis.Cell2010;140:49-61 PMCID:PMC2885975

[103] Rozeveld CN,Zhang L.KRAS controls pancreatic cancer cell lipid metabolism and invasive potential through the lipase HSL.Cancer Res2020;80:4932-45 PMCID:PMC7669720

[104] Wright HJ,Xu B.CDCP1 drives triple-negative breast cancer metastasis through reduction of lipid-droplet abundance and stimulation of fatty acid oxidation.Proc Natl Acad Sci U S A2017;114:E6556-65 PMCID:PMC5559020

[105] Criscuolo D,Calice G.Cholesterol homeostasis modulates platinum sensitivity in human ovarian cancer.Cells2020;9:828 PMCID:PMC7226826

[106] VandeKopple MJ,Auer EN,Denko NC.HILPDA regulates lipid metabolism, lipid droplet abundance, and response to microenvironmental stress in solid tumors.Mol Cancer Res2019;17:2089-101 PMCID:PMC6774878

[107] Tse C,Farook R.Phytochemical targeting of STAT3 orchestrated lipid metabolism in therapy-resistant cancers.Biomolecules2020;10:1118 PMCID:PMC7464013

[108] Cruz ALS,Fazolini NPB,Bozza PT.Lipid droplets: platforms with multiple functions in cancer hallmarks.Cell Death Dis2020;11:105 PMCID:PMC7005265

[109] Yang WH,Wu J,Murphy SK.A TAZ-ANGPTL4-NOX2 axis regulates ferroptotic cell death and chemoresistance in epithelial ovarian cancer.Mol Cancer Res2020;18:79-90 PMCID:PMC6942206

[110] Alexa-Stratulat T,Gašparović AČ,Riganti C.What sustains the multidrug resistance phenotype beyond ABC efflux transporters? Looking beyond the tip of the iceberg.Drug Resist Updat2019;46:100643

[111] Dubey R,Nguyen HQ.Lipid droplets can promote drug accumulation and activation.Nat Chem Biol2020;16:206-13 PMCID:PMC6989039

[112] Englinger B,Moser P.Lipid droplet-mediated scavenging as novel intrinsic and adaptive resistance factor against the multikinase inhibitor ponatinib.Int J Cancer2020;147:1680-93 PMCID:PMC7497038

[113] Sirois I,Lafleur J.A unique morphological phenotype in chemoresistant triple-negative breast cancer reveals metabolic reprogramming and PLIN4 expression as a molecular vulnerability.Mol Cancer Res2019;17:2492-507

[114] Curtarello M,Venturoli C.Rewiring of lipid metabolism and storage in ovarian cancer cells after anti-VEGF therapy.Cells2019;8:1601 PMCID:PMC6953010

[115] She K,Du W.SCD1 is required for EGFR-targeting cancer therapy of lung cancer via re-activation of EGFR/PI3K/AKT signals.Cancer Cell Int2019;19:103 PMCID:PMC6472070

[116] Huang Q,Li D.Co-administration of 20(S)-protopanaxatriol (g-PPT) and EGFR-TKI overcomes EGFR-TKI resistance by decreasing SCD1 induced lipid accumulation in non-small cell lung cancer.J Exp Clin Cancer Res2019;38:129 PMCID:PMC6419820

[117] Tan SK,Fontanesi F.Obesity-dependent adipokine chemerin suppresses fatty acid oxidation to confer ferroptosis resistance.Cancer Discov2021;11:2072-93 PMCID:PMC8338847

[118] Song X,Kuang F.PDK4 dictates metabolic resistance to ferroptosis by suppressing pyruvate oxidation and fatty acid synthesis.Cell Rep2021;34:108767

[119] Lee H,Kondiparthi L.Cell cycle arrest induces lipid droplet formation and confers ferroptosis resistance.Nat Commun2024;15:79 PMCID:PMC10761718

[120] Luis G,Nishiumi S.Tumor resistance to ferroptosis driven by Stearoyl-CoA Desaturase-1 (SCD1) in cancer cells and Fatty Acid Biding Protein-4 (FABP4) in tumor microenvironment promote tumor recurrence.Redox Biol2021;43:102006 PMCID:PMC8163990

[121] Wang SA,Yang FM,Zhang K.NCI677397 targeting USP24-mediated induction of lipid peroxidation induces ferroptosis in drug-resistant cancer cells.Mol Oncol2024;18:2255-76

[122] Luo J,Li Y.Reversing ferroptosis resistance in breast cancer via tailored lipid and iron presentation.ACS Nano2023;17:25257-68

[123] Thomas M,Nell T,Engelbrecht AM.Amino acid starvation sensitizes resistant breast cancer to doxorubicin-induced cell death.Front Cell Dev Biol2020;8:565915 PMCID:PMC7593593

[124] Dash S,Komuro A.MYC/glutamine dependency is a therapeutic vulnerability in pancreatic cancer with deoxycytidine kinase inactivation-induced gemcitabine resistance.Mol Cancer Res2023;21:444-57

[125] Xu L,Butler W.Targeting glutamine metabolism network for the treatment of therapy-resistant prostate cancer.Oncogene2022;41:1140-54 PMCID:PMC9985769

[126] Zhou X,Rao X.Activated amino acid response pathway generates apatinib resistance by reprograming glutamine metabolism in non-small-cell lung cancer.Cell Death Dis2022;13:636 PMCID:PMC9304404

[127] Kim G,Kim YJ.Inhibition of glutamine uptake resensitizes paclitaxel resistance in SKOV3-TR ovarian cancer cell via mTORC1/S6K signaling pathway.Int J Mol Sci2022;23:8761 PMCID:PMC9369036

[128] Wang Z,Li R.Sijunzi Tang improves gefitinib resistance by regulating glutamine metabolism.Biomed Pharmacother2023;167:115438

[129] Chen P,Lin X,Zhang S.Targeting YTHDF1 effectively re-sensitizes cisplatin-resistant colon cancer cells by modulating GLS-mediated glutamine metabolism.Mol Ther Oncolytics2021;20:228-39 PMCID:PMC7873577

[130] Lee ACK,Kwan YW.Mitochondrial fuel dependence on glutamine drives chemo-resistance in the cancer stem cells of hepatocellular carcinoma.Int J Mol Sci2021;22:3315 PMCID:PMC8036982

[131] Ren J,Sun R.Augmented drug resistance of osteosarcoma cells within decalcified bone matrix scaffold: The role of glutamine metabolism.Int J Cancer2024;154:1626-38

[132] Morotti M,El-Ansari R.Increased expression of glutamine transporter SNAT2/SLC38A2 promotes glutamine dependence and oxidative stress resistance, and is associated with worse prognosis in triple-negative breast cancer.Br J Cancer2021;124:494-505 PMCID:PMC7852531

[133] Ying L,Lu Y.Glutamine metabolism scoring predicts prognosis and therapeutic resistance in hepatocellular carcinoma.Pathol Oncol Res2021;27:1610075 PMCID:PMC8724684

[134] Fu S,Xiao L.Glutamine synthetase promotes radiation resistance via facilitating nucleotide metabolism and subsequent DNA damage repair.Cell Rep2019;28:1136-43.e4

[135] Pan M,Sugaya M.Glutamine deficiency in solid tumor cells confers resistance to ribosomal RNA synthesis inhibitors.Nat Commun2022;13:3706 PMCID:PMC9240073

[136] Okazaki S,Yamasaki J.Glutaminolysis-related genes determine sensitivity to xCT-targeted therapy in head and neck squamous cell carcinoma.Cancer Sci2019;110:3453-63 PMCID:PMC6825010

[137] Yoo HC,Nam M.A variant of SLC1A5 is a mitochondrial glutamine transporter for metabolic reprogramming in cancer cells.Cell Metab2020;31:267-83.e12

[138] Li B,Meng G.Targeting glutaminase 1 attenuates stemness properties in hepatocellular carcinoma by increasing reactive oxygen species and suppressing Wnt/beta-catenin pathway.EBioMedicine2019;39:239-54 PMCID:PMC6355660

[139] Hu Q,Zhang Z.ASS1-mediated reductive carboxylation of cytosolic glutamine confers ferroptosis resistance in cancer cells.Cancer Res2023;83:1646-65

[140] Kim JH,Im SS.Glutamine-mediated epigenetic regulation of cFLIP underlies resistance to TRAIL in pancreatic cancer.Exp Mol Med2024;56:1013-26 PMCID:PMC11058808

[141] Ishak Gabra MB,Li H.Dietary glutamine supplementation suppresses epigenetically-activated oncogenic pathways to inhibit melanoma tumour growth.Nat Commun2020;11:3326 PMCID:PMC7335172

[142] Abid MA.Commentary: dietary methionine influences therapy in mouse cancer models and alters human metabolism.Front Oncol2020;10:1071 PMCID:PMC7357428

[143] Gao X,Dai Z.Dietary methionine influences therapy in mouse cancer models and alters human metabolism.Nature2019;572:397-401 PMCID:PMC6951023

[144] Wang Z,Lee JHJ.Methionine is a metabolic dependency of tumor-initiating cells.Nat Med2019;25:825-37

[145] Strekalova E,Weisenhorn EMM.S-adenosylmethionine biosynthesis is a targetable metabolic vulnerability of cancer stem cells.Breast Cancer Res Treat2019;175:39-50 PMCID:PMC6494685

[146] Bacci M,Ippolito L.Reprogramming of amino acid transporters to support aspartate and glutamate dependency sustains endocrine resistance in breast cancer.Cell Rep2019;28:104-18.e8 PMCID:PMC6616584

[147] Sun J,Zaal EA.SLC1A3 contributes to L-asparaginase resistance in solid tumors.EMBO J2019;38:e102147 PMCID:PMC6826201

[148] Krall AS,Surjono F.Asparagine couples mitochondrial respiration to ATF4 activity and tumor growth.Cell Metab2021;33:1013-26.e6 PMCID:PMC8102379

[149] Jiang J,Seim G.Promoter demethylation of the asparagine synthetase gene is required for ATF4-dependent adaptation to asparagine depletion.J Biol Chem2019;294:18674-84 PMCID:PMC6901317

[150] Hinze L,Karim S.Synthetic lethality of wnt pathway activation and asparaginase in drug-resistant acute leukemias.Cancer Cell2019;35:664-76.e7 PMCID:PMC6541931

[151] Saito Y,Coyaud E.LLGL2 rescues nutrient stress by promoting leucine uptake in ER⁺ breast cancer.Nature2019;569:275-9

[152] Shindo H,Ebata A.Targeting amino acid metabolic reprogramming via L-type amino acid transporter 1 (LAT1) for endocrine-resistant breast cancer.Cancers2021;13:4375 PMCID:PMC8431153

[153] Wang Y,Ren S.Branched-chain amino acid metabolic reprogramming orchestrates drug resistance to EGFR tyrosine kinase inhibitors.Cell Rep2019;28:512-25.e6

[154] Sivanand S.Emerging roles for branched-chain amino acid metabolism in cancer.Cancer Cell2020;37:147-56 PMCID:PMC7082774

[155] Luo L,Zhu W.BCAT1 decreases the sensitivity of cancer cells to cisplatin by regulating mTOR-mediated autophagy via branched-chain amino acid metabolism.Cell Death Dis2021;12:169 PMCID:PMC7876012

[156] Montrose DC,Foronda M.Exogenous and endogenous sources of serine contribute to colon cancer metabolism, growth, and resistance to 5-fluorouracil.Cancer Res2021;81:2275-88 PMCID:PMC8137552

[157] Engel AL,Klann K.Serine-dependent redox homeostasis regulates glioblastoma cell survival.Br J Cancer2020;122:1391-8 PMCID:PMC7188854

[158] Zhao X,Tang W,Xu W.Inhibition of serine metabolism promotes resistance to cisplatin in gastric cancer.Onco Targets Ther2020;13:4833-42 PMCID:PMC7269635

[159] Hu W,Zhu S.Small extracellular vesicle-mediated Hsp70 intercellular delivery enhances breast cancer adriamycin resistance.Free Radic Biol Med2021;164:85-95

[160] Wu J,Shen J.Effect of modified Jianpi Yangzheng on regulating content of PKM2 in gastric cancer cells-derived exosomes.Phytomedicine2022;103:154229

[161] Zhou S,Li Y,Pu J.Hypoxic tumor-derived exosomes induce M2 macrophage polarization via PKM2/AMPK to promote lung cancer progression.Cell Transplant2022;31:9636897221106998 PMCID:PMC9280815

[162] Li G,Li Y.Hypoxic microenvironment-induced exosomes confer temozolomide resistance in glioma through transfer of pyruvate kinase M2.Discov Oncol2024;15:110 PMCID:PMC11006647

[163] Wang D,Xu F.Cisplatin-resistant NSCLC cells induced by hypoxia transmit resistance to sensitive cells through exosomal PKM2.Theranostics2021;11:2860-75 PMCID:PMC7806469

[164] Alharbi M,Sharma S.Extracellular vesicle transmission of chemoresistance to ovarian cancer cells is associated with hypoxia-induced expression of glycolytic pathway proteins, and prediction of epithelial ovarian cancer disease recurrence.Cancers2021;13:3388 PMCID:PMC8305505

[165] Wang C,Yuan D.Exosomes carrying ALDOA and ALDH3A1 from irradiated lung cancer cells enhance migration and invasion of recipients by accelerating glycolysis.Mol Cell Biochem2020;469:77-87

[166] Wu X,Xu S.Extracellular vesicle packaged LMP1-activated fibroblasts promote tumor progression via autophagy and stroma-tumor metabolism coupling.Cancer Lett2020;478:93-106

[167] Sung JS,Kang S.ITGB4-mediated metabolic reprogramming of cancer-associated fibroblasts.Oncogene2020;39:664-76

[168] Morrissey SM,Ding C.Tumor-derived exosomes drive immunosuppressive macrophages in a pre-metastatic niche through glycolytic dominant metabolic reprogramming.Cell Metab2021;33:2040-58.e10 PMCID:PMC8506837

[169] Wang S,Xu M.Exosomes secreted by mesenchymal stromal/stem cell-derived adipocytes promote breast cancer cell growth via activation of Hippo signaling pathway.Stem Cell Res Ther2019;10:117 PMCID:PMC6458638

[170] Lazar I,Dauvillier S.Adipocyte exosomes promote melanoma aggressiveness through fatty acid oxidation: a novel mechanism linking obesity and cancer.Cancer Res2016;76:4051-7

[171] Clement E,Attané C.Adipocyte extracellular vesicles carry enzymes and fatty acids that stimulate mitochondrial metabolism and remodeling in tumor cells.EMBO J2020;39:e102525 PMCID:PMC6996584

[172] Zhang Q,Zhang H.Adipocyte-derived exosomal MTTP suppresses ferroptosis and promotes chemoresistance in colorectal cancer.Adv Sci2022;9:e2203357 PMCID:PMC9534973

[173] Yang Y,Zhang K.Exosomal ACADM sensitizes gemcitabine-resistance through modulating fatty acid metabolism and ferroptosis in pancreatic cancer.BMC Cancer2023;23:789 PMCID:PMC10463774

[174] Lee HC,Huang YC.YAP1 overexpression contributes to the development of enzalutamide resistance by induction of cancer stemness and lipid metabolism in prostate cancer.Oncogene2021;40:2407-21 PMCID:PMC8016667

[175] Yang SJ,Li J.Predictive role of GSTP1-containing exosomes in chemotherapy-resistant breast cancer.Gene2017;623:5-14

[176] Hu X,Xu B.Glutamine metabolic microenvironment drives M2 macrophage polarization to mediate trastuzumab resistance in HER2-positive gastric cancer.Cancer Commun2023;43:909-37 PMCID:PMC10397568

[177] Hill M.miRNA interplay: mechanisms and consequences in cancer.Dis Model Mech2021;14:dmm047662 PMCID:PMC8077553

[178] Qi R,Li K.Cancer-associated fibroblasts suppress ferroptosis and induce gemcitabine resistance in pancreatic cancer cells by secreting exosome-derived ACSL4-targeting miRNAs.Drug Resist Updat2023;68:100960

[179] Zhang H,Liu R.CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer.Mol Cancer2020;19:43 PMCID:PMC7045485

[180] Chang Y,Jiang Y.Alpha-hederin reprograms multi-miRNAs activity and overcome small extracellular vesicles-mediated paclitaxel resistance in NSCLC.Front Pharmacol2024;15:1257941 PMCID:PMC10867254

[181] Alharbi M,Guanzon D.miRNa signature in small extracellular vesicles and their association with platinum resistance and cancer recurrence in ovarian cancer.Nanomedicine2020;28:102207

[182] Zhuang L,Liu X.Exosomal miR-21-5p derived from cisplatin-resistant SKOV3 ovarian cancer cells promotes glycolysis and inhibits chemosensitivity of its progenitor SKOV3 cells by targeting PDHA1.Cell Biol Int2021;45:2140-9

[183] Wang H,Pan H.Exosomes derived from macrophages enhance aerobic glycolysis and chemoresistance in lung cancer by stabilizing c-myc via the inhibition of NEDD4L.Front Cell Dev Biol2020;8:620603 PMCID:PMC7969980

[184] Chen F,Yang L.Extracellular vesicle-packaged HIF-1α-stabilizing lncRNA from tumour-associated macrophages regulates aerobic glycolysis of breast cancer cells.Nat Cell Biol2019;21:498-510

[185] Li Y,Liu W.SNHG3 functions as miRNA sponge to promote breast cancer cells growth through the metabolic reprogramming.Appl Biochem Biotechnol2020;191:1084-99 PMCID:PMC7320061

[186] Zhang H,He Y.Chemotoxicity-induced exosomal lncFERO regulates ferroptosis and stemness in gastric cancer stem cells.Cell Death Dis2021;12:1116 PMCID:PMC8629982

[187] Li C.Exosome-derived circ_0094343 promotes chemosensitivity of colorectal cancer cells by regulating glycolysis via the miR-766-5p/TRIM67 axis.Contrast Media Mol Imaging2022;2022:2878557 PMCID:PMC9286929

[188] Shi Q,Ma Z,Liang J.Serum exosomes-based biomarker circ_0008928 regulates cisplatin sensitivity, tumor progression, and glycolysis metabolism by miR-488/HK2 axis in cisplatin-resistant nonsmall cell lung carcinoma.Cancer Biother Radiopharm2023;38:558-71

[189] Ma J,Li L.A novel serum exosomes-based biomarker hsa_circ_0002130 facilitates osimertinib-resistance in non-small cell lung cancer by sponging miR-498.Onco Targets Ther2020;13:5293-307 PMCID:PMC7293392

[190] Zeng Z,Chen Q.Hypoxic exosomal HIF-1α-stabilizing circZNF91 promotes chemoresistance of normoxic pancreatic cancer cells via enhancing glycolysis.Oncogene2021;40:5505-17

[191] Tan WQ,Wu XY,Zhu SC.Exosome-delivered circular RNA DLGAP4 induces chemoresistance via miR-143-HK2 axis in neuroblastoma.Cancer Biomark2022;34:375-84

[192] Wang B,Hou D.Exosomes derived from acute myeloid leukemia cells promote chemoresistance by enhancing glycolysis-mediated vascular remodeling.J Cell Physiol2019;234:10602-14

[193] Li F,Dong Q.Tumor-derived exosome-educated hepatic stellate cells regulate lactate metabolism of hypoxic colorectal tumor cells via the IL-6/STAT3 pathway to confer drug resistance.Onco Targets Ther2020;13:7851-64 PMCID:PMC7423356

[194] Chen Y,Zhai L.Metabolic regulation of homologous recombination repair by MRE11 lactylation.Cell2024;187:294-311.e21

[195] Fang K,Qiu F,Xiong H.Serum-derived exosomes-mediated circular RNA ARHGAP10 modulates the progression of non-small cell lung cancer through the miR-638/FAM83F axis.Cancer Biother Radiopharm2022;37:96-110

[196] Tang KD,Zhang X.Proteomic alterations in salivary exosomes derived from human papillomavirus-driven oropharyngeal cancer.Mol Diagn Ther2021;25:505-15

[197] Lin J,Zhai S.Hypoxia-induced exosomal circPDK1 promotes pancreatic cancer glycolysis via c-myc activation by modulating miR-628-3p/BPTF axis and degrading BIN1.J Hematol Oncol2022;15:128 PMCID:PMC9450374

[198] Yi X,Hu X,Liu T.Changes in phospholipid metabolism in exosomes of hormone-sensitive and hormone-resistant prostate cancer cells.J Cancer2021;12:2893-902 PMCID:PMC8040901

[199] Sanchez JI,Kwan SY.Lipidomic profiles of plasma exosomes identify candidate biomarkers for early detection of hepatocellular carcinoma in patients with cirrhosis.Cancer Prev Res2021;14:955-62 PMCID:PMC8546639

[200] Tao L,Yuan C.Metabolomics identifies serum and exosomes metabolite markers of pancreatic cancer.Metabolomics2019;15:86

[201] Palacios-Ferrer JL,Gallardo-Gómez M.Metabolomic profile of cancer stem cell-derived exosomes from patients with malignant melanoma.Mol Oncol2021;15:407-28 PMCID:PMC7858120

[202] Ou B,Gao Z.Senescent neutrophils-derived exosomal piRNA-17560 promotes chemoresistance and EMT of breast cancer via FTO-mediated m6A demethylation.Cell Death Dis2022;13:905 PMCID:PMC9613690

[203] Pan Y,Shu G.Extracellular vesicle-mediated transfer of LncRNA IGFL2-AS1 confers sunitinib resistance in renal cell carcinoma.Cancer Res2023;83:103-16 PMCID:PMC9811158

[204] Wan L,Du Y.Exosomes from activated hepatic stellate cells contain GLUT1 and PKM2: a role for exosomes in metabolic switch of liver nonparenchymal cells.FASEB J2019;33:8530-42

[205] Lv B,Feng C.Coptisine blocks secretion of exosomal circCCT3 from cancer-associated fibroblasts to reprogram glucose metabolism in hepatocellular carcinoma.DNA Cell Biol2020;39:2281-8

[206] Du J,Wang C.Designer exosomes for targeted and efficient ferroptosis induction in cancer via chemo-photodynamic therapy.Theranostics2021;11:8185-96 PMCID:PMC8344009

[207] Liu J,Xiang M.Functional extracellular vesicles engineered with lipid-grafted hyaluronic acid effectively reverse cancer drug resistance.Biomaterials2019;223:119475

[208] Lin D,Liu R.iRGD-modified exosomes effectively deliver CPT1A siRNA to colon cancer cells, reversing oxaliplatin resistance by regulating fatty acid oxidation.Mol Oncol2021;15:3430-46 PMCID:PMC8637580